Skip all navigation Skip to page navigation
 
 

North Carolina Health Officials Investigating Product from Compounding Pharmacy

 

Pat McCrory, Governor
Aldona Z. Wos, M.D., Secretary

For Immediate Release
May 24, 2013
Contact: news@dhhs.nc.gov 919-855-4840

RALEIGH – The North Carolina Department of Health and Human Services and the North Carolina Board of Pharmacy are participating with other local, state and federal health agencies in an investigation of products prepared by a compounding manufacturer, Main Street Family Pharmacy of Newbern, Tennessee that were shipped to three North Carolina clinics. The North Carolina investigation began after the FDA was notified of two individuals who developed complications after administration of an injectable steroid product at a clinic in Greenville, N.C. Main Street Family Pharmacy has issued a voluntary recall of all sterile products.State and local public health officials are working with the three clinics that received the formulation of methylprednisolone acetate, a steroid product, associated with the investigation. The clinics involved are Carolina Arthritis Center in Pitt County, Bailey Family Practice Center in Nash County, and Shallote Medical Center in Brunswick County. The clinics are notifying patients who may have been exposed to alert them to any signs and symptoms of complications. As a precaution, the N.C. Board of Pharmacy has contacted the clinics and asked that all products from the pharmacy be quarantined and the pharmacy has agreed to voluntary surrender its North Carolina pharmacy license.

Complications identified thus far are skin abscesses. Health officials have not had any reports of meningitis, stroke, or death. Any individuals who are experiencing any unexplained health problems following an injection of methylprednisolone acetate from one of these clinics are encouraged to contact the administering clinic or their regular health care provider.

###

 

State of North Carolina Home Page